In response to growing European market demands, Randox Laboratories has launched a new liquid frozen, multiplatform immunoassay control. All Randox controls are true third-party controls, manufactured independently using quality screened human serum. The controls are designed for use in the routine monitoring of accuracy and precision in patient sample testing.
The immunoassay control has been developed following extensive research and includes cardiac markers (troponin I and troponin T), routine tumour markers (CA15-3, CA19-9, CA125, ?2-microglobulin, fPSA and tPSA) and specialist immunoassays (anti-TPO, androstenedione, insulin and IGF-1).
The immunoassay control is available in three levels and is unassayed enabling laboratories to assign their own values and ranges. Stability for the thawed serum is variable (depending on analyte) but will be stable for up to seven days when stored between +20C and +80C.
www.randox.com
